MTOR and central nervous system cancer: In order to confirm the involvement of the RAS-RAF-MEK-ERK and PI3K-AKT/PKB mTOR pathways in the resistance of gliomas to the induction of programmed cell death, the first elements of these signaling pathways, i.e., RAF and PI3K, were blocked with specific siRNA (Figure 8).